| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/04/2010 | US20100028334 Compositions and methods to potentiate colistin activity |
| 02/04/2010 | US20100028332 Antagonists of actriib and uses for increasing red blood cell levels |
| 02/04/2010 | US20100028331 Antagonists of activin-actriia and uses for increasing red blood cell levels |
| 02/04/2010 | US20100028328 Topical treatment for diseases of eye surface |
| 02/04/2010 | US20100028327 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 02/04/2010 | US20100028326 Diagnosis of hyperinsulinemia and type ii diabetes and protection against same based on proteins differentially expressed in serum |
| 02/04/2010 | US20100028324 Creating Designer Antimicrobials; Peptidoglycan Hydrolase Module Shuffling |
| 02/04/2010 | US20100028322 Antimetastatic effect on human cell disorders |
| 02/04/2010 | US20100028321 Drug target for preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health |
| 02/04/2010 | US20100028320 Methods and Compositions for Inhibiting Diseases of the Central Nervous System |
| 02/04/2010 | US20100028319 Composition for prevention or treatment of diabetes |
| 02/04/2010 | US20100028318 Agent for relief or prevention of xerostomia |
| 02/04/2010 | US20100028317 Skin Repair Compositions Comprising Circadian Gene Activators And A Synergistic Combination Of Sirt1 Gene Activators |
| 02/04/2010 | US20100028302 Use of IGFBP-2 in Senescence Diseases and for the Maintenance of Organ Functions |
| 02/04/2010 | US20100028301 IMIDAZO[4,5-c]PYRIDINE COMPOUNDS AND METHODS OF ANTIVIRAL TREATMENT |
| 02/04/2010 | US20100028300 Macrocyclic peptides active against the hepatitis c virus |
| 02/04/2010 | US20100028299 Methods and compositions of treating a flaviviridae family viral infection |
| 02/04/2010 | US20100028298 Interferon type i supporting compounds |
| 02/04/2010 | US20100028297 Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis |
| 02/04/2010 | US20100028296 Use of cytokine-derived peptides in treatment of pain and neurodegenerative disease |
| 02/04/2010 | US20100026235 Charging Control in an Electric Vehicle |
| 02/04/2010 | DE19681438B4 Verwendung von Polypeptidanaloga mit erhöhter Elektrotransportierbarkeit und Parathormon (PTH) - Analog Use of polypeptide analogs with increased Elektrotransportierbarkeit and parathyroid hormone (PTH) - Analog |
| 02/04/2010 | DE102008036576A1 Partikel aus Kollagenmaterial und Verfahren zur Herstellung Particles of collagenous material and processes for making |
| 02/04/2010 | DE102008035299A1 Conjugate, particularly bromovinyl-deoxyuridine for manufacture medicament for inhibiting or suppressing metastasis including distant metastases in cytostatic treatment, includes heat shock protein and nucleoside |
| 02/04/2010 | DE102008034098A1 Zubereitung und lontophoretische Vorrichtung für die transdermale Anwendung von Wirkstoffen Preparation and iontophoretic device for transdermal application of active substances |
| 02/04/2010 | CA2732948A1 Use of a soluble form of hla-g in the treatment of abnormal b-lymphocyte proliferation |
| 02/04/2010 | CA2732763A1 Methods for treating reperfusion injuries |
| 02/04/2010 | CA2732721A1 Melk epitope peptides and vaccines containing the same |
| 02/04/2010 | CA2732575A1 Immunotherapy compositions for the treatment and prevention of amyloidosis |
| 02/04/2010 | CA2732574A1 Multi-specific binding proteins targeting b cell disorders |
| 02/04/2010 | CA2732439A1 Halogen-stabilized insulin |
| 02/04/2010 | CA2732146A1 Nonimmunosuppressive cyclosporine analogue molecules |
| 02/04/2010 | CA2732108A1 Prominin-1 peptide fragments and uses thereof |
| 02/04/2010 | CA2730659A1 Recombinant preparation of bromelain inhibitors and bromelain inhibitor precursor |
| 02/04/2010 | CA2718750A1 Preparation method of biodegradable micro-particles containing drugs |
| 02/03/2010 | EP2149604A1 Collections of repeat proteins comprising repeat modules |
| 02/03/2010 | EP2149585A1 Antagonist anti-CD40 monoclonal antibodies and methods for their use |
| 02/03/2010 | EP2149584A1 Method for enhancing immune response with peptide |
| 02/03/2010 | EP2149583A1 Modified VP1-capsid protein of parvovirus B19 |
| 02/03/2010 | EP2149380A1 Veterinary immunotherapy compositions for the Aged Related Cognitive Dysfunction. |
| 02/03/2010 | EP2149369A1 Instant oral formulations, gelling at room temperature, useful to treat physical wasting and the depressive syndrome associated with cachexia, anorexia, metabolic disorders, endocrine disorders and dysphagia |
| 02/03/2010 | EP2148726A1 Secreted frizzled related protein 3 for use in the inhibition of scarring |
| 02/03/2010 | EP2148708A1 Composition for enhancing bone formation |
| 02/03/2010 | EP2148696A1 Surfaces, methods and devices employing cell rolling |
| 02/03/2010 | EP2148694A2 Pharmaceutical agent for the treatment of fertility and gestation disorders, immunological diseases, and transplantation for use in veterinary medicine, particularly in horses, and methods for the production and treatment monitoring thereof |
| 02/03/2010 | EP2148693A2 Alpha-i antitrypsin having no significant serine protease inhibitor activity |
| 02/03/2010 | EP2148691A2 Local complement inhibition for treatment of complement-mediated disorders |
| 02/03/2010 | EP2148663A2 Pulmonary delivery of spherical insulin microparticles |
| 02/03/2010 | EP2148641A1 Treatment of movement disorders by a combined use of botulinum toxin and muscle stimulation |
| 02/03/2010 | EP1773876B1 Hpv vaccine comprising peptides from host cell proteins |
| 02/03/2010 | EP1351679B1 Method and composition for the treatment of diabetic neuropathy |
| 02/03/2010 | CN101641114A Treatment of inflammation and/or endotoxic shock |
| 02/03/2010 | CN101641113A Prophylactic agent for heart failure |
| 02/03/2010 | CN101638437A Growth hormone fusion protein |
| 02/03/2010 | CN101637611A Ocular gene therapy |
| 02/03/2010 | CN101637608A Mixture of tubercle bacillus HSP and tumor lysate |
| 02/03/2010 | CN100586474C Medicine composition, kit and application thereof |
| 02/02/2010 | US7655787 Circularly permuted molecule carrying stabilized, properly folded, biologically active moiety; intracellular degradation resistance; selex; genetic engineering |
| 02/02/2010 | US7655781 Variants of human glycoprotein hormone alpha chain: compositions and uses thereof |
| 02/02/2010 | US7655780 Integrin-linked kinase and its uses |
| 02/02/2010 | US7655775 Recombinant vectors for treating E coli infections more specifically those that result in post weaning diarrhea or scours; lactic acid bacterium |
| 02/02/2010 | US7655772 Administering a natriuretic hormone peptide (NHP), or a nucleic acid sequence encoding NHP; respiratory system disorders |
| 02/02/2010 | US7655771 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 02/02/2010 | US7655770 Nucleic acid molecules and other molecules associated with the phosphogluconate pathway |
| 02/02/2010 | US7655766 Partially dePEGylated lysine/N-terminal positional PEG isomers of a recombinant G-CSF polypeptide, such recombinant G-CSF polypeptide containing the substitutions K16R, K34R, K40R, T105K and S159K relative to wild-type human G-CSF; increasing the level of neutrophils in a patient |
| 02/02/2010 | US7655765 Modified Fc molecules |
| 02/02/2010 | US7655764 immunoglobulin domain peptides having myostatin, erythropoietin or thrombopoietin peptides as an internal sequence, preferably in a loop region of the domain; antibodies |
| 02/02/2010 | US7655760 Antibodies to the polypeptide hormone phosphatonin |
| 02/02/2010 | US7655759 Recombinant bivalent monospecific immunoglobulin having at least two variable fragments of heavy chains of an immunoglobulin devoid of light chains |
| 02/02/2010 | US7655756 Peptide fragment comprising the Ligand Binding Domain (LBD) of ERR gamma in complex with Bisphenol A; used to design or select compounds which have an effect on ERR gamma activity; drug screening |
| 02/02/2010 | US7655755 Breast cancer resistance protein (BCRP) and the DNA which encodes it |
| 02/02/2010 | US7655753 Conjugate |
| 02/02/2010 | US7655752 TNF-α converting enzyme inhibitory agents and method of using same |
| 02/02/2010 | US7655751 An EGFR-reactive cytotoxic T lymphocyte which recognizes a complex between the EGFR-derived peptide and human leukocyte antigen (HLA) molecule; anticarcinogenic agent |
| 02/02/2010 | US7655717 Ointment composition for treating decubitus ulcers and methods for its making and its use |
| 02/02/2010 | US7655676 Selective activity against propionibacterium acne; minimum inhibitory concentration (MIC) against Propionibacterium acnes strains both sensitive and resistant to erythromycin and clindamycin and against a series Staphylococcus strains |
| 02/02/2010 | US7655635 Suppression of nuclear factor-κB dependent processes using oligonucleotides |
| 02/02/2010 | US7655634 Use of hepatitis B X-interacting protein (HBXIP) in modulation of apoptosis |
| 02/02/2010 | US7655631 Pharmaceutical preparations and methods for inhibiting tumors |
| 02/02/2010 | US7655630 Abuse-resistant amphetamine prodrugs |
| 02/02/2010 | US7655629 Peptides and their use for the treatment of HIV infections |
| 02/02/2010 | US7655628 Method for treating liver cirrhosis or interstitial pulmonary fibrosis |
| 02/02/2010 | US7655627 Mutein of human FGF-21 containing an engineered disulfide where cysteine replaces leucine 118 and alanine 134, alanine for serine 167; reduced deamidation and capacity of O-glycosylation compared to wild-type human FGF-21; antidiabetic agents, type 2 diabetes; obesity; metabolic syndrome |
| 02/02/2010 | US7655626 Antiangiogenic peptides |
| 02/02/2010 | US7655625 Administering cyclosporin A to the eye or eyelid of a human or animal afflicted with, for example, suffering from or having, blepharospasm not resulting from local ocular surface or ocularsurface disease; primary/secondary blepharospasm; Parkinson'sdisease; tartive dystonia |
| 02/02/2010 | US7655624 Peptide and peptide mimetic conjugates with integrin-inhibitor properties |
| 02/02/2010 | US7655623 Dab9 derivatives of lipopeptide antibiotics and methods of making and using the same |
| 02/02/2010 | US7655622 Administering melanocyte stimulating hormone to peripheral tissue |
| 02/02/2010 | US7655621 Cross-linked glycopeptide-cephalosporin antibiotics |
| 02/02/2010 | US7655620 Use of one or more metal carriers to selectively kill mammalian cells |
| 02/02/2010 | US7655619 Insulin-associated peptides with effects on cerebral health |
| 02/02/2010 | US7655618 Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
| 02/02/2010 | US7655617 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 02/02/2010 | US7655616 Traumatic brain and spinal cord injury treatment; administering interleukin-1B converting enzyme (capsase-1) inhibitor |
| 02/02/2010 | US7655615 Surface and/or the interior of bone material is charged with bone morphogenic proteins and is sheathed with resorbable material |
| 02/02/2010 | US7655602 Peptides comprising aromatic D-amino acids and methods of use |
| 02/02/2010 | US7655472 compositions and methods to suppress the activation and/or proliferation of mesenchymally derived cells, as well as cells with abnormal growth characteristics; inhibit or eliminate fibrosis; cancer |
| 02/02/2010 | US7655463 Treating neuropathic pain, particularly diabetic peripheral neuropathy, by administering a truncated neublastin polypeptide; activating a RET receptor tyrosine kinase |
| 02/02/2010 | US7655462 Anti-tumor activity of Ea-4-peptide of pro-IGF-I |
| 02/02/2010 | US7655459 Enhancer contains interleukin as an effective component and is co-administered with a recombinant herpes simplex virus that selectively replicates in cancer cells |